Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients
Keyword(s):
2011 ◽
Vol 28
(2)
◽
pp. 82-88
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 21
(2)
◽
pp. 114-122
◽